ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "biomarkers and nephritis"

  • Abstract Number: 2850 • 2016 ACR/ARHP Annual Meeting

    Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis

    Joan Wither1, Stephenie Prokopec2, Babak Noamani1, Dennisse Bonilla1, Zahi Touma3, Carmen Avila-Casado4, Heather Reich5, James Scholey5, Paul R. Fortin6, Paul Boutros2 and Carolina Landolt-Marticorena1, 1Krembil Research Institute, University Health Network, Toronto, ON, Canada, 2Ontario Institute for Cancer Research, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Pathology, University Health Network, Toronto, ON, Canada, 5Nephrology, University Health Network, Toronto, ON, Canada, 6Université Laval, CHU de Québec, Québec, QC, Canada

    Background/Purpose:  The relapsing and remitting nature of lupus nephritis (LN) poses a challenge to clinicians who must balance the risk of long term kidney damage…
  • Abstract Number: 2863 • 2016 ACR/ARHP Annual Meeting

    High Frequency of Terminally Differentiated CD8+ T Cells Characterize Systemic Lupus Erythematosus Patients with Renal Involvement

    Nataly Manjarrez-Orduño1, Laurence Menard1, Julie Carman1, Suzanne Suchard1, Francesca Casano1, Deborah Lee1, Sium Habte1, Sherif Daouti2, Selena Kansal3, Dana Banas3, Can Jiang3, Dawn Stetsko3, Mark Cunningham3, Vivek Jayaswal4, Somnath Bandyopadhyay3, Sarah Hu3, Richard A. Furie5 and Steven G. Nadler6, 1Discovery Translational Sciences Group, Bristol-Myers Squibb, Princeton, NJ, 2Bristol-Myers Squibb, Princeton, NY, 3Bristol-Myers Squibb, Princeton, NJ, 4Biocon Bristol-Myers Squibb Research Center, Bangalore, India, 5Division of Rheumatology, Northwell Health, Great Neck, NY, 6Immunosciences Translational Research, Bristol-Myers Squibb, Princeton, NJ

    Background/Purpose: SLE is a highly heterogeneous disease. The identification of disease subtypes with different pathological mechanisms is crucial to identify subjects with different disease progression…
  • Abstract Number: 1070 • 2015 ACR/ARHP Annual Meeting

    CD 14(C-159T) Polymorphism and Soluble CD14 Are Associated with Increased Disease Activity and Nephritis in SLE

    Sarit sekhar Pattanaik1, Aditya kumar Panda2, Rashmi ranjan Sahoo1, Rina Tripathy3 and Bidyut kumar Das1, 1Medicine, SCB Medical College, Cuttack, India, 2Centre for Life science, Central University of Jharkand, Ranchi, India, 3Biochemistry, SCB Medical College, Cuttack, India

    Background/Purpose: Cluster of differentiation 14 (CD14) plays an important role in innate immune system as a co-receptor in TLRs (2, 4, 7 and 9) signaling.…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences